that was technically important this morning to hold the support at 22. hopefully we now go higher. Darn shorts are still in control.
My calcs are indicating a range of $3.20-$3.30 per share (have to guesstimate Europe, Japan, and VA) and based on that Fair Value would be $132-$140 based on Cash Flow, using a 12% cash flow discount ratio.
Analyst expectations are in the $2.60-$2.70 range.
Congrats, but note that bulls make money, pigs get slaughtered ... so an experienced player would sell at least 50% here. but who am I, this is an anonymous message board and I could be a short (which I am not).
ha ha, thanks for that ... always good to get a little breathe of fresh bear (although it can be a little smelly). unfortunately your post does not answer my question, which is: 'including the warrants and convertibles, how many shares are outstanding'.
NEA distributed the shares to their partners who then went on a selling spree on Tuesday morning at the open ... and possibly towards the close today. i like SUPN, looking for a good entry which is around these levels now.
Doing some DD here, assuming SGYP received a $1.5 Billion offer, does that mean the value per share is just under $9 for the 'fully diluted outstanding' shares and warrants' ?
hey optiontrader, I remember you from the ANIK board. I am long here as well just initiating a position today, hoping for a decent move north. Good Luck !
something clearly leaked ... SHPG is considering a 12 billion pound ($18.32 billion) takeover of Actelion Ltd (ATLN.VX) Europe's biggest biotech firm, Britain's Sunday Times newspaper reported, citing unnamed sources. Lets see what transpires this upcoming week